Browsing: Eli Lilly

Eli Lilly is gearing up to invest over $1 billion in India, dramatically boosting its manufacturing power to keep pace with the skyrocketing demand across the region, Reuters reports

Eli Lilly has temporarily paused UK orders of its diabetes medication Mounjaro ahead of an upcoming price hike, aiming to prevent potential stockpiling. This move carefully manages supply to meet rising demand while preparing for the new pricing structure

Eli Lilly’s recent launch of Mounjaro in India has sparked a surge in inquiries about weight-loss solutions. The new drug, aimed at managing obesity, has captured significant attention, reflecting a growing demand for effective weight management options in the country.

Eli Lilly is set to introduce its weight-loss drug in emerging markets this year, aiming to address rising obesity rates. The launch follows successful outcomes in developed regions, positioning Lilly to expand its global footprint in the competitive weight management sector.